Aptose Biosciences Inc

NASDAQ:APTO   3:58:09 PM EDT
1.23
-0.04 (-3.07%)
5:13:25 PM EDT: $1.23 0.00 (-0.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aptose Biosciences Inc Stock, NASDAQ:APTO

251 Consumers Road, Suite 1105, Toronto, Ontario M2J 4R3
Canada
Phone: +1.647.479.9828
Number of Employees: 35
http://www.aptose.com

Description

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.